Jessica Chubak, PhD, is an epidemiologist who works to improve cancer diagnosis, treatment, control, and survivorship. She contributes to several national collaborations that are finding practical, efficient, effective ways to screen for cancer, especially colorectal cancer. She also studies how common medications affect cancer risk and recurrence. Intrigued by how pets positively affect health, Dr. Chubak is studying animal-assisted activities in clinics and hospitals where children get treated for cancer. Dr. Chubak’s methodological research focuses on the use of administrative and electronic health record data in epidemiologic and health services studies.
Dr. Chubak joined KPWHRI in 2007, bringing expertise in epidemiologic methods, pharmacoepidemiology, and cancer. Awarded a Fulbright graduate student grant, Dr. Chubak pursued her master's degree in bioethics and health law in New Zealand before completing her PhD in Epidemiology at the University of Washington (UW). Dr. Chubak is an affiliate associate professor in the Department of Epidemiology at the UW School of Public Health, where she enjoys guest-lecturing and getting to work with students.
Epidemiology; colorectal cancer; medication use; survivorship; recurrence; secondary prevention; quality of life; automated data collection; screening; animal-assisted activities; survivorship
Screening
Cancer risk and use of common medications
Tong J, Huang J, Chubak J, Wang X, Moore JH, Hubbard RA, Chen Y. An augmented estimation procedure for EHR-based association studies accounting for differential misclassification. J Am Med Inform Assoc. 2019 Oct 16. pii: 5588595. doi: 10.1093/jamia/ocz180. [Epub ahead of print]. PubMed
Lee JK, Jensen CD, Levin TR, Doubeni CA, Zauber AG, Chubak J, Kamineni AS, Schottinger JE, Ghai NR, Udaltsova N, Zhao WK, Fireman BH, Quesenberry CP, Orav EJ, Skinner CS, Halm EA, Corley DA. Long-term risk of colorectal cancer and related death after adenoma removal in a large, community-based population. Gastroenterology. 2019 Oct 4. pii: S0016-5085(19)41411-X. doi: 10.1053/j.gastro.2019.09.039. [Epub ahead of print]. PubMed
Check DK, Hutcheson KA, Poisson LM, Pocobelli G, Sakoda LC, Zaveri J, Chang SS, Chubak J. Factors associated with employment discontinuation among older and working age survivors of oropharyngeal cancer. Head Neck. 2019 Sep 6. doi: 10.1002/hed.25943. [Epub ahead of print]. PubMed
Burnett-Hartman AN, Kamineni A, Corley DA, Singal AG, Halm EA, Rutter CM, Chubak J, Lee JK, Doubeni CA, Inadomi JM, Doria-Rose VP, Zheng Y. Colonoscopy indication algorithm performance across diverse health care systems in the PROSPR consortium. eGEMS (Wash DC). 2019;7(1):37. doi: 10.5334/egems.296. PubMed
Barlow WE, Beaber EF, Geller BM, Kamineni A, Zheng Y, Haas JS, Chao CR, Rutter CM, Zauber AG, Sprague BL, Halm EA, Weaver DL, Chubak J, Doria-Rose VP, Kobrin S, Onega T, Quinn VP, Schapira MM, Tosteson ANA, Corley DA, Skinner CS, Schnall MD, Armstrong K, Wheeler CM, Silverberg MJ, Balasubramanian BA, Doubeni CA, McLerran D, Tiro JA. Evaluating screening participation, follow-up and outcomes for breast, cervical and colorectal cancer in the PROSPR consortium. J Natl Cancer Inst. J Natl Cancer Inst. 2020 Mar 1;112(3):238-246. doi: 10.1093/jnci/djz137. PubMed
Pocobelli G, Ziebell R, Fujii M, Hutcheson KA, Chang S, McClure JB, Chubak J. Symptom burden in long-term survivors of head and neck cancer: patient-reported versus clinical data. EGEMS (Wash DC). 2019;7(1):25. doi: 10.5334/egems.271. PubMed
Burnett-Hartman AN, Chubak J, Hua X, Ziebell R, Kamineni A, Zhu LC, Upton MP, Malen RC, Hardikar S, Newcomb PA. The association between colorectal sessile serrated adenomas/polyps and subsequent advanced colorectal neoplasia. Cancer Causes Control. 2019 Jul 9. pii: 10.1007/s10552-019-01205-y. doi: 10.1007/s10552-019-01205-y. [Epub ahead of print]. PubMed
Understanding emergency department use among adolescent and young adult cancer survivors can help address care gaps.
How KPWHRI is contributing to better cancer screening and better outcomes for patients.
Top pediatric oncology hospitals reported lasting changes to programs involving visits with animals.